i3 Announces 4 New Deals at 4th Access to Markets Event, Driving the Future of Healthcare Innovation Across Africa

Kigali, Rwanda. Tuesday, 29th September, 2026 – Investing in Innovation Africa (i3), a pan-African initiative designed to help African healthtech startups scale and commercialize their offerings, today announced 4 strategic partnerships between leading African healthtech innovators and global, regional, and private sector partners at its 4th annual Access to Markets (A2M) event.

The new transformative deals will focus on supporting chronic disease care, expanding patient access to affordable and safe medicines, and strengthening pharmacy regulation through digital and artificial intelligence systems.

Rubayat Khan, Director of Health Programs, Endless commented: "Chronic disease care in East Africa is being delivered through private pharmacies whether the system plans for it or not. What is missing is evidence about whether that channel can deliver quality, not just convenience, which is exactly what this partnership with MYDAWA and Ariadne Labs is designed to produce."

“Private pharmacies remain a critical first point of care for people living with noncommunicable and chronic diseases such as hypertension and diabetes, which are increasingly prevalent across Africa. This partnership gives us an opportunity to make access more affordable and strengthen care delivery for patients in their own communities,” said Priscilla Muhiu, Group COO of MYDAWA.

“Everyone deserves access to safe, high-quality medicines, irrespective of where you live. Today, Meditect is helping make this a reality in Sub-Saharan Africa. By strengthening trusted pharmaceutical supply chains and helping patients access authentic medicines, Meditect is also playing a critical role in tackling the widespread challenge of counterfeit and substandard medicines across the region. We are proud to support their expansion, ensuring that more patients can more easily find affordable and authentic pharmaceuticals, whenever and wherever they might need them. I'm excited to see how they'll scale up their enormous potential in the future,” shared Aditya Peri, Associate Director at Boehringer Ingelheim.

These deals build on i3’s proven track record of deal facilitation for African health startups, having generated over 760 bespoke introductions, resulting in 165 partnerships, pilots and Memorandums of Understanding valued at over $19 million. As of April 2026, i3 innovators have served over 6.85 million patients and tracked, protected and distributed over 209 million health products, demonstrating i3’s growing impact on patients’ access to essential care and safe medicines across Africa. 

Held alongside the Africa HealthTech Summit, this year's A2M event convened 20 leading local innovators, including i3’s current Future of Pharmacy cohort - Chefaa, Dawa Mkononi, Meditect, mPharma, MYDAWA, Sproxil, and Zuri Health. Together, they are expanding patient access and safety through 3,500 health facilities across 19 African countries, helping strengthen the continent’s health systems and improve quality healthcare delivery. 

A2M was also attended by 57 leading global and regional industry players, including GAVI, J&J, Pfizer, BillionScale Health, AMREF, and several government institutions creating a unique platform for collaboration between innovators, investors, policymakers and healthcare stakeholders to accelerate the adoption of scalable healthcare solutions across Africa.

Speaking at this year’s event, Oladunni Lawal, Investing in Innovation Lead, said: “African innovators are reshaping healthcare delivery across the region, with solutions designed to address local gaps and reach the communities and patients who need them most. Through Access to Markets, we are bringing regional and global partners closer to these businesses, opening commercial opportunities that enable their innovations to deliver greater health impact. Now in its fourth year, A2M is demonstrating the value of this approach, with today’s deals committing financing and expertise to stronger pharmacy networks and more accessible chronic disease care.” 

Access to Markets is i3's flagship event for collaboration between Africa's leading healthtech innovators and regional and global health organizations and industry players, offering a unique platform for networking, end-to-end deal facilitation, and market partnerships that create sustainable pathways for growth and enable locally developed solutions to deliver impact at scale.

i3 is supported by its dedicated sponsors–the Gates Foundation, MSD, Cencora, Endless Health, HELP Logistics, Sanofi, and Boehringer Ingelheim–and implemented by Salient Advisory and the Solina Centre for International Development and Research (SCIDaR).

— ENDS —

For additional information, please contact  Salient@wimbart.com 

About i3

Launched in 2022, the Investing in Innovation (i3) program is a pan-African initiative aiming to support African healthtech start-ups to commercialize and scale their offerings, by connecting them to a global network of donors, governments, and the private sector to champion both economic and health outcomes. i3 is funded by the Gates Foundation, and sponsored by MSD, Cencora, Endless Health, HELP Logistics, Sanofi, and Boehringer Ingleheim.

About the Gates Foundation 

Guided by the belief that every life has equal value, the Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we work with partners to create impactful solutions so that people can take charge of their futures and achieve their full potential. In the United States, we aim to ensure that everyone—especially those with the fewest resources—has access to the opportunities needed to succeed in school and life. https://www.gatesfoundation.org/  

About MSD 

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on X (formerly Twitter) , LinkedIn and YouTube.

About Cencora 

Formerly known as AmerisourceBergen, Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s 46,000+ worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $290 billion in annual revenue. Learn more at http://cencora.com. 

About Endless Health 

Focused on empowering communities through holistic and integrated primary care, Endless Health makes catalytic investments in innovative tools and interventions that enhance healthcare access and outcomes, such as enabling patients and frontline providers with AI, engaging pharmacies in primary care, and aligning provider incentives with patient-centered measures of experience and outcomes. Their mission is to bridge healthcare gaps worldwide by leveraging technology to create sustainable, inclusive health systems. Learn more at https://www.endlessnetwork.com/initiative-health.html  

About HELP Logistics 

As a unique non-profit subsidiary of the Kühne Foundation, HELP Logistics AG has been advancing logistics excellence in the humanitarian and development sectors since 2014. Headquartered in Switzerland, we operate across the Middle East, Africa, Asia-Pacific and Europe. Our mission is to act as a global catalyst for advancing supply chain and logistics expertise to enhance the lives, opportunities, and resilience of people, communities, and economies worldwide. For more information, visit: https://www.help-logistics.org 

About Sanofi’s Global Health Unit 

Sanofi’s Global Health Unit is a pioneering, not-for-profit social business model with a mission to improve the lives of underserved populations in 40 countries with the highest unmet medical needs. We achieve this through innovative, inclusive healthcare models and partnerships, delivering a sustainable impact. Established in 2022, the Impact Investment Fund is focused on supporting the scale-up of businesses to improve access to healthcare by supporting startup companies and other innovators who can deliver scalable solutions for healthcare in underserved regions. For more information, visit: https://www.impact.sanofi/. 

About Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com. 

About Salient Advisory 

Launched in 2020 with a globally distributed team in Kenya, Nigeria and Canada, Salient Advisory helps changemakers enact transformative approaches to health. The company analyses and supports partnerships to use technology and innovations, adapt policy and financing, and elevate unheard voices to change global conversations and transform access to care. Learn more at https://www.salientadvisory.com/. 

About SCIDaR 

SCIDaR is an indigenous, Nigeria-based health systems consulting and implementation non-profit organisation that works with governments, development organisations, and the private sector to optimise population health outcomes. It applies proven business and market-shaping techniques and utilises its relationships and understanding of Africa's public and private sector health system actors to ensure sustainable impact. Learn more at https://scidar.org/.

About Chefaa

Chefaa is an AI-powered GPS enabled platform which enables patients to order, schedule and refill their prescriptions across Egypt. Orders can be fulfilled in 90 minutes through partner pharmacies or pre-scheduled at discounted prices. Differentiates itself through medication guides, medication reminders and telepharmacy services. Chefaa also provides data and insights for pharma companies, insurance and BNPL offerings to retail pharmacies. Learn more at www.chefaa.health.

About Dawa Mkononi

Dawa Mkononi is a B2B pharmaceutical supply chain platform leveraging technology and embedded financing to streamline medicine distribution for drug shops, pharmacies, clinics, and hospitals. Differentiates itself through AI-driven demand forecasting, real-time inventory tracking, and a buy-now-pay-later model powered by an in-house credit scoring system, ensuring fast, affordable, and compliant medicine procurement. Learn more at www.dawamkononi.co.tz.

About mPharma

mPharma enables access to health products through a vast chain of retail pharmacies operating across 8 countries. For providers, mPharma provides inventory management services, ensuring availability of quality medicines. For patients, mPharma provides a range of primary care services, leveraging nurses, physicians, and pharmacists. Learn more at www.mpharma.com.

About MYDAWA

MYDAWA is a hybrid digital and physical healthcare platform operating a bricks-and-clicks model to provide medications, teleconsultations, diagnostics, and insurance-integrated healthcare. Differentiates itself through vertically integrated generics manufacturing, which drives lower costs (up to 30%) and ensures quality, making healthcare more affordable and accessible. Learn more at www.mydawa.com.

About Meditect

Meditect is a B2B SaaS platform digitizing pharmacy management and data-driven healthcare analytics across Francophone Africa. Differentiates itself through cloud-based pharmacy management software, AI-powered credit scoring for instant financing, and data monetization for pharmaceutical companies and public health organizations. Learn more at www.meditect.com.

About Sproxil

Sproxil started as a mobile-based drug authentication platform tackling counterfeit medicines but has evolved into a comprehensive healthtech solution. In addition to its product protection and visibility offerings, it now provides real-time pharmaceutical market data (Sproxil Surveys), an AI-powered patient engagement platform (AISHA), and tech-driven accountability systems to improve supply chain transparency, medication safety, and public health decision-making. Learn more at www.sproxil.com.

About Zuri Health 

Zuri Health is a virtual hospital and full-service telemedicine platform that delivers on-demand care through its mobile app, website, WhatsApp chatbot, and SMS. Patients speak with licensed doctors, order medicines through an integrated online pharmacy, and receive doorstep delivery. They book lab and diagnostic tests, get samples collected at home, and share results with clinicians for follow up. The platform also supports home visits and structured chronic care programs, giving patients continuous, coordinated support outside traditional facilities. Zuri Health’s model brings a complete primary care experience into a single, easy-to-use digital service. Learn more at https://zuri.health/

New Channels for Product Introduction & Patient Access: The Growth of Healthtech in Africa 

More than 300 health supply chain innovators are building an entirely new healthcare channel across Africa—one that's already reaching hundreds of thousands of patients daily and has the potential to reshape access for millions more patients. 

Hundreds of healthtech startups launched across Africa around the COVID-19 pandemic. Since then, the channel has been growing steadily. Today, the collective reach and potential to expand patient access, reduce market entry barriers for manufacturers, and provide governments with scalable pathways to deliver health products and services is substantial.

From Pilots to Patients: 300,000 Daily Touchpoints and Counting 

In December 2025, 15 leading African healthtech innovators gathered at the Investing in Innovation Africa Access to Markets event in Lagos, Nigeria: Advantage Health, Chefaa, Dawa Mkononi, Elephant, Field Inc., Meditect, mPharma, MYDAWA, Pharmarun, Purelife Pharmacy, Zuri Health, Kapsule, Figorr, Sproxil, and Remedial Health. The data they shared on the healthcare facilities they’re serving, revealing an ecosystem already operating at meaningful scale. Collectively:

This is no longer just a collection of apps or pilot projects – it’s infrastructure reaching real people with real healthcare products and services. 

Healthtech’s reach is growing in Francophone and Southern Africa 

Today, Nigeria and Kenya account for nearly 90% of facilities served by leading healthtech companies. But the map is shifting. Leading healthtech companies expect to reach >18K providers in Francophone Africa and >30K providers in Southern Africa by 2028.

While most innovators are serving private facilities with digital services, Field Inc. stands as a notable exception, reaching nearly 30K public facilities through large-scale government programs — a glimpse of what public-private integration could look like at scale. 

The Real Bottlenecks: Contracts and Capital 

To power their expansion, the 15 innovators consistently point to two critical enablers: public and private partnerships, and access to working capital. Collaborations with pharmaceutical manufacturers and wholesalers provide the steady product flow necessary to serve providers reliably. Long-term contracts with governments and global health institutions anchor these innovators within national health priorities, supporting new product launches and coordinated service delivery. 

Additionally, working capital is needed to purchase inventory, extend credit to providers, expand into rural areas where margins are thin. 

What Happens Next Depends on Who’s Paying Attention 

Realizing the full potential of this channel requires coordinated investment, strategic partnerships, and supportive policy environments. Investors must recognize these networks as healthcare infrastructure providers, not just tech startups. Manufacturers need to see them as viable routes to market. Governments should engage them as partners in delivering against national health priorities. And global health institutions can leverage them to accelerate progress toward universal health coverage. 

The channel exists. The scale is emerging. The opportunity now is to ensure that this reach delivers a lasting, equitable impact. In a continent long defined by gaps in healthcare access, innovators are building networks that work, scale that matters, and pathways that reach those who have historically been left behind.
 

Check out our short explainer video on the reach of these new channels!
 

A New Way to Scale Healthtech Impact: Inside i3's 2025 Access to Markets Event

"i3 was created to demonstrate a new way of supporting startups' commercialization and growth," notes Mara Hansen Staples who helped launch i3 in 2022. "The healthtech ecosystem didn't need more accelerators or incubators - coming out of these programs, leading startups needed customers who could help them bring their innovations to impactful and sustainable scale. By purposefully connecting leaders from startups and large healthcare organizations, we hoped to help create value for patients and systems alike."

In Lagos in December, the Investing in Innovation program—coordinated by Salient Advisory and Solina Center for International Development and Research (SCIDaR)—hosted its 3rd annual Access to Markets event, facilitating over 100 bespoke meetings between Africa’s leading healthtech companies and strategic partners across the continent – all focused on advancing novel partnerships between startups and major healthcare organizations that will sustainably advance patient access. 

“2025 was a wake-up call – the need to work urgently across public and private sectors to find ways to lower costs and sustainably expand patient access became clear. The commitment, creativity and progress that infused Access to Markets this year illustrates how healthcare leaders from all corners are stepping up to create partnerships that serve African patients in new ways,” noted 'Dunni Lawal, who leads the i3 program for Salient Advisory.

The 2025 invite-only event brought together pioneering executives who committed to imagining and enacting new ways of working. Thirteen leading healthtech innovators were joined by 43 healthcare executives from government institutions, global pharmaceutical companies, investors, donors, and ecosystem partners for 1:1 meetings, workshops on corporate strategies and startup engagement opportunities, and more. One startup CEO noted, “I made more progress in 2 days than I usually make in 2 months.”

“At i3 we’re very clear that facilitating meetings with startups is not sufficient – i3 is committed to helping our partners launch large-scale partnerships that help them sustainably expand access for patients,” said Somto Keluo-Udeke, of the i3 program. In this spirit, i3 announced 3 transformative new deals between leading African healthtech startups and global and regional healthcare actors to advance cervical cancer prevention, malaria care and pharmacy-based access. MSD and MYDAWA unveiled a collaboration to advance cervical cancer elimination that will expand access to at-home and in-clinic vaccination for HPV, supported by online booking tools and educational counselling. An MOU between Nigeria's National Malaria Elimination Programme (NMEP), the Presidential Initiative for Unlocking the Healthcare Value Chain under the Federal Ministry of Health, and Sproxil to combat malaria by improving access to diagnostics and treatments. The partnership leverages Sproxil’s test-to-treat model and AI-powered malaria surveillance to provide real-time data from pharmacies and patent medicine vendors, enabling collaboration with pharmaceutical manufacturers and giving NMEP insights to track distribution, monitor disease patterns, and ensure accountability. And finally, Boehringer Ingelheim’s Social Engagement Fund celebrated recent investments in 3 companies driving the future of pharmacy across Africa: Dawa Mkononi (a member of the latest i3 cohort), Kasha, and Reach52. 

A few years ago i3 was just an idea on how to work differently to jumpstart commercialization and impact - its vision is now coming to fruition. And folks are excited to see a new approach to supporting social innovation working; we had nearly 30 pieces of media reporting on the event - including coverage from Nigeria’s Channels News and CNBC. If you’d like to meet any of the companies present to explore how digitally-enabled startups might help advance your goals, please reach out. If you’re committed to building new partnerships with startups to advance patient access, and would like to be considered for an invitation for the 2026 event, please let us know. 

i3 Announces 3 Groundbreaking Deals at 3rd Access to Markets Event, Significantly Advancing African Healthtech Innovation

Lagos, Nigeria - 10 December 2025 Investing in Innovation Africa (i3) held its 3rd flagship Access to Markets (A2M) event, a two-day gathering designed to connect Africa's most promising healthtech companies with strategic partners who can accelerate their commercialization, scale, and impact through contracts, pilots, partnerships, and investments. 

On the opening day, i3 announced 3 new transformative deals between leading African healthtech startups and global and regional healthcare actors—collaborations that will advance cervical cancer prevention, pharmacy-based access, and malaria care. 

MSD and MYDAWA unveiled a collaboration aimed at supporting MYDAWA in enhancing their concierge channel services to strengthen efforts related to cervical cancer elimination. Through this initiative, MYDAWA will expand access to health-related services, such as at-home and in-clinic options, supported by online booking tools and educational counselling. MSD’s contribution focuses on business and technical expertise, which demonstrates how a collaboration between regional and global innovators can develop new healthcare solutions to people through novel, patient-centered models that help reduce barriers to accessing healthcare. NOTE: This initiative is centered on improving access to information and services. It does not involve the supply, promotion or distribution of any vaccines or medicinal products that are not registered.

“We’re excited to support MYDAWA in improving access to healthcare, powered by purpose and technology. Together, we’re meeting communities where they are, forging new paths for patient access and creating health markets. This is how we break down barriers across Africa—through collaborations that enable sustainable and scalable solutions,” said Dr. Priya Agrawal, Vice President, International Health Equity and Partnerships, MSD.

A Memorandum of Understanding between Nigeria's National Malaria Elimination Programme (NMEP), the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) under the Federal Ministry of Health, and Sproxil to combat malaria by improving access to diagnostics and treatments. The partnership leverages Sproxil’s test-to-treat model and AI-powered malaria surveillance to provide real-time data from pharmacies and patent medicine vendors, enabling collaboration with pharmaceutical manufacturers and giving NMEP insights to track distribution, monitor disease patterns, and ensure accountability. This initiative supports Nigeria’s targets of reducing malaria prevalence to below 10% and malaria-related deaths to under 50 per 1,000 live births.

Commenting on the partnership with PVAC and NMEP, Dr. Ashifi Gogo, CEO and Founder of Sproxil said: "We are honored to partner with Nigeria's National Malaria Elimination Programme (NMEP) and the Presidential Initiative For Unlocking the Healthcare Value Chain (PVAC) in deploying AI-enhanced surveillance infrastructure that transforms every consumer product verification into timely epidemiological intelligence. This partnership demonstrates that African-led solutions, when properly supported, can drive continental health transformation while ensuring affordable anti-malarials reach the children and families who need them most."

Boehringer Ingelheim’s Social Engagement Fund celebrated recent investments in 3 companies driving the future of pharmacy across Africa: Dawa Mkononi (a member of the latest i3 cohort), Kasha, and Reach52. “We are delighted to invest in three additional startups that deliver a strong impact to communities across Africa,” says Dr. Ilka Wicke, Head of Sustainability Social. “These partnerships reflect our belief that sustainable healthcare solutions are best built through collaboration – with local innovators who understand the needs on the ground and with global partners who can help scale their vision. Together, we’re making meaningful progress toward our goal of improving the lives of 50 million people by 2030. We’re thrilled to celebrate progress with our partners who share this vision across the i3 program.”

Since July, i3 has been working closely with leading innovators focused on the future of pharmacy care in Africa – Chefaa, Dawa Mkononi, Meditect, mPharma, MYDAWA, Sproxil and Zuri Health–  completing more than 110 bespoke introductions to customers and investors, generating 15 partnerships with a potential value exceeding $20 million. At an unprecedented pace of more than one advancing partnership per week, i3 continues to deliver best-in-class growth advisory support to African healthtech innovators. 

This year’s A2M brought together 15 leading African healthtech startups, whose innovations already power more than 66K healthcare providers across 12 African countries and are on track to reach over 167K providers by 2028, demonstrating a powerful channel for improving patient access and strengthening health systems.

A2M also convened 41 prominent investors, global and regional pharmaceutical manufacturers, donors, development finance institutions, and multilateral agencies—including Grand Challenges Canada, IFC, World Bank, Pfizer, Causal Foundry, Proqurable, Federal Ministry of Health, PVAC, and i3’s sponsors—who are all working to accelerate scalable innovations, create jobs, and expand healthcare impact across the continent. 

“Leading healthtech startups are an increasingly powerful force across Africa, reshaping the continent’s healthcare landscape. Through Access to Markets, these innovators are linked with strategic, high-impact partners across industry, government, donors, and global health agencies, enabling them to better scale their solutions. This approach is rapidly delivering tangible results, as evidenced by the more than 100 meetings being held at this year’s event and the 3 deals announced today,” said Oladunni Lawal, Investing in Innovation's Lead. 

The event program also includes senior government participation, notably keynote speaker Dr. Abdu Mukhtar, National Coordinator of the Presidential Initiative for Unlocking the Healthcare Chain, and Dr. Leke Ojewale, Senior Technical Adviser to the Minister of Health for Nigeria.

Through initiatives like A2M, i3 is helping build a sustainable, digitally enabled future for African healthcare–one where locally led innovation, supported by global and regional partnerships, drives lasting impact at scale. i3 is supported by dedicated sponsors – the Gates Foundation, MSD, Cencora, Endless Health, HELP Logistics, Sanofi, and Boehringer Ingelheim.

—-- ENDS —---- 

For additional information, please contact  Salient@wimbart.com  

About i3

Launched in 2022, the Investing in Innovation (i3) program is a pan-African initiative aiming to support African healthtech start-ups to commercialize and scale their offerings, by connecting them to a global network of donors, governments, and the private sector to champion both economic and health outcomes. i3 is funded by the Gates Foundation, and sponsored by MSD, Cencora, Endless Health, HELP Logistics, Sanofi, and Boehringer Ingleheim.

About the Gates Foundation 

Guided by the belief that every life has equal value, the Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we work with partners to create impactful solutions so that people can take charge of their futures and achieve their full potential. In the United States, we aim to ensure that everyone—especially those with the fewest resources—has access to the opportunities needed to succeed in school and life. https://www.gatesfoundation.org/  

About MSD 

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on X (formerly Twitter) , LinkedIn and YouTube.

About Cencora 

Formerly known as AmerisourceBergen, Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s 46,000+ worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $290 billion in annual revenue. Learn more at http://cencora.com. 

About Endless Health 

Focused on empowering communities through holistic and integrated primary care, Endless Health makes catalytic investments in innovative tools and interventions that enhance healthcare access and outcomes, such as enabling patients and frontline providers with AI, engaging pharmacies in primary care, and aligning provider incentives with patient-centered measures of experience and outcomes. Their mission is to bridge healthcare gaps worldwide by leveraging technology to create sustainable, inclusive health systems. Learn more at https://www.endlessnetwork.com/initiative-health.html  

About HELP Logistics 

As a unique non-profit subsidiary of the Kühne Foundation, HELP Logistics AG has been advancing logistics excellence in the humanitarian and development sectors since 2014. Headquartered in Switzerland, we operate across the Middle East, Africa, Asia-Pacific and Europe. Our mission is to act as a global catalyst for advancing supply chain and logistics expertise to enhance the lives, opportunities, and resilience of people, communities, and economies worldwide. For more information, visit: https://www.help-logistics.org 

About Sanofi’s Global Health Unit 

Sanofi’s Global Health Unit is a pioneering, not-for-profit social business model with a mission to improve the lives of underserved populations in 40 countries with the highest unmet medical needs. We achieve this through innovative, inclusive healthcare models and partnerships, delivering a sustainable impact. Established in 2022, the Impact Investment Fund is focused on supporting the scale-up of businesses to improve access to healthcare by supporting startup companies and other innovators who can deliver scalable solutions for healthcare in underserved regions. For more information, visit: https://www.impact.sanofi/. 

Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com. 

About Salient Advisory 

Launched in 2020 with a globally distributed team in Kenya, Nigeria and Canada, Salient Advisory helps changemakers enact transformative approaches to health. The company analyses and supports partnerships to use technology and innovations, adapt policy and financing, and elevate unheard voices to change global conversations and transform access to care. Learn more at https://www.salientadvisory.com/. 

About SCIDaR 

SCIDaR is an indigenous, Nigeria-based health systems consulting and implementation non-profit organisation that works with governments, development organisations, and the private sector to optimise population health outcomes. It applies proven business and market-shaping techniques and utilises its relationships and understanding of Africa's public and private sector health system actors to ensure sustainable impact. Learn more at https://scidar.org/.

About Chefaa

Chefaa is an AI-powered GPS enabled platform which enables patients to order, schedule and refill their prescriptions across Egypt. Orders can be fulfilled in 90 minutes through partner pharmacies or pre-scheduled at discounted prices. Differentiates itself through medication guides, medication reminders and telepharmacy services. Chefaa also provides data and insights for pharma companies, insurance and BNPL offerings to retail pharmacies. Learn more at www.chefaa.health.

About Dawa Mkononi

Dawa Mkononi is a B2B pharmaceutical supply chain platform leveraging technology and embedded financing to streamline medicine distribution for drug shops, pharmacies, clinics, and hospitals. Differentiates itself through AI-driven demand forecasting, real-time inventory tracking, and a buy-now-pay-later model powered by an in-house credit scoring system, ensuring fast, affordable, and compliant medicine procurement. Learn more at www.dawamkononi.co.tz.

About mPharma

mPharma enables access to health products through a vast chain of retail pharmacies operating across 8 countries. For providers, mPharma provides inventory management services, ensuring availability of quality medicines. For patients, mPharma provides a range of primary care services, leveraging nurses, physicians, and pharmacists. Learn more at www.mpharma.com.

About MYDAWA

MYDAWA is a hybrid digital and physical healthcare platform operating a bricks-and-clicks model to provide medications, teleconsultations, diagnostics, and insurance-integrated healthcare. Differentiates itself through vertically integrated generics manufacturing, which drives lower costs (up to 30%) and ensures quality, making healthcare more affordable and accessible. Learn more at www.mydawa.com.

About Meditect

Meditect is a B2B SaaS platform digitizing pharmacy management and data-driven healthcare analytics across Francophone Africa. Differentiates itself through cloud-based pharmacy management software, AI-powered credit scoring for instant financing, and data monetization for pharmaceutical companies and public health organizations. Learn more at www.meditect.com.

About Sproxil

Sproxil started as a mobile-based drug authentication platform tackling counterfeit medicines but has evolved into a comprehensive healthtech solution. In addition to its product protection and visibility offerings, it now provides real-time pharmaceutical market data (Sproxil Surveys), an AI-powered patient engagement platform (AISHA), and tech-driven accountability systems to improve supply chain transparency, medication safety, and public health decision-making. Learn more at www.sproxil.com.

About Zuri Health 

Zuri Health is a virtual hospital and full-service telemedicine platform that delivers on-demand care through its mobile app, website, WhatsApp chatbot, and SMS. Patients speak with licensed doctors, order medicines through an integrated online pharmacy, and receive doorstep delivery. They book lab and diagnostic tests, get samples collected at home, and share results with clinicians for follow up. The platform also supports home visits and structured chronic care programs, giving patients continuous, coordinated support outside traditional facilities. Zuri Health’s model brings a complete primary care experience into a single, easy-to-use digital service. Learn more at https://zuri.health/

i3 Selects Leading African Startups Transforming Pharmacy Care to Receive Up to $225K & Impact Support from the Gates Foundation, MSD & More

April 30th, 2025 - Lagos, Nigeria - Investing in Innovation Africa (i3), a pan-African initiative to support African healthtech startups to commercialise and scale their offerings, has announced its 3rd cohort of growth-stage companies working to transform pharmacy services on the continent. Sponsored by the Gates Foundation, MSD, Cencora (formerly AmerisourceBergen), Endless Foundation, HELP Logistics (a subsidiary of the Kühne Foundation), Sanofi’s Global Health Unit and Chemonics, the three-year program will empower innovators to improve patient access to healthcare across Africa and scale their impact. 

In many African countries, pharmacies serve on the frontline of healthcare delivery, providing as much as 70% of initial healthcare visits. For this cohort, i3 has prioritised growth-stage startups with pharmacy-focused innovations, recognising their vital role in expanding sustainable healthcare access and bridging critical delivery gaps while creating jobs to spur economic growth and prosperity. 

The selected startups offer powerful, tech-enabled solutions that strengthen pharmacy services across Africa, ranging from inventory management, product protection, last-mile delivery, AI-powered prescription refills, embedded financing, and cloud-based pharmacy systems. These companies are reimagining how medicines and health services reach patients, making essential care more accessible, affordable, and safer.

The selected startups are: 

Together, they demonstrate how data-driven innovation reinforces the resilience of Africa’s health systems while driving economic growth. Operating in 19 countries across the continent, they show the power of locally grounded, scalable solutions to improve patient outcomes, create jobs, and enable more efficient, data-driven healthcare delivery at scale.

Each innovator will receive up to $225K in risk-tolerant funding, tailored customer introductions, bespoke deal facilitation, and professional communications and advocacy support. i3 aims to facilitate ~150 strategic partnerships and influence deals valued at ~$30M between innovators and major healthcare purchasers. In addition, the cohort will participate in i3’s flagship Access to Markets event in December 2025, designed to spark high-impact partnerships between innovators and large healthcare companies, governments, donors, and multilateral agencies.

Boniface Njenga, Deputy Director, Health Delivery and Systems, Africa at the Gates Foundation, commented: “As the global health landscape continues to rapidly shift, we remain committed to supporting innovative solutions and initiatives that strengthen local health systems across Africa. The i3 program emphasises the transformative potential of technology-driven innovations on the continent when empowered with the right resources, and we have already seen impressive results from the cohorts.”

Dr. Priya Agrawal, Vice President, International Health Equity and Partnerships, MSD, noted: “Now more than ever, investing in local healthcare businesses is essential for securing effective and sustainable medicine and vaccine distribution across Africa. MSD is committed to partnering with i3 to support entrepreneurs that are dedicated to expanding equitable healthcare access. By engaging the local private sector and meeting patients where they are, we can enhance access and strengthen health systems through fostering innovation in pharmacy services.”

Dr. Ashifi Gogo, CEO and Founder at Sproxil, remarked: “It is an honor to be selected as part of the i3 cohort focused on growth-stage companies. The support of leading global life sciences and logistics companies, alongside forward-thinking foundations, is encouraging as we scale our impact. The i3 program continues to differentiate itself through the transformative power of local innovation, and I am eager to see the significant impact this cohort will undoubtedly make."

In the past two years, i3 has provided $3M in direct grant funding to 60 start-ups across 18 African countries. The program has also established a diverse cohort of innovators, with 43% being women-led and 20% Francophone-led. Finally, successes have recorded 450 facilitated strategic connections, including 122 contracts and pilots, resulting in >$11M in contracted partnerships, expanded reach, and nearly 1,000 jobs created—half of which were held by women. 

i3 is coordinated by Salient Advisory and Solina Center for International Development and Research (SCIDaR). Startups were selected by an expert committee and with the support of CcHUB and Villgro Africa and an independent expert advisory committee.  

For more information about the program, please visit https://innovationsinafrica.com/ 

-ENDS-

For additional information, please contact  Salient@wimbart.com 

About the Gates Foundation 

Guided by the belief that every life has equal value, the Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we work with partners to create impactful solutions so that people can take charge of their futures and achieve their full potential. In the United States, we aim to ensure that everyone—especially those with the fewest resources—has access to the opportunities needed to succeed in school and life. https://www.gatesfoundation.org/  

About MSD 

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on X (formerly Twitter) , LinkedIn and YouTube.

About Cencora 

Formerly known as AmerisourceBergen, Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s 46,000+ worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $290 billion in annual revenue. Learn more at http://cencora.com. 

About Endless Health 

Focused on empowering communities through holistic and integrated primary care, Endless Health makes catalytic investments in innovative tools and interventions that enhance healthcare access and outcomes, such as enabling patients and frontline providers with AI, engaging pharmacies in primary care, and aligning provider incentives with patient-centered measures of experience and outcomes. Their mission is to bridge healthcare gaps worldwide by leveraging technology to create sustainable, inclusive health systems. Learn more at https://www.endlessnetwork.com/initiative-health.html  

About HELP Logistics 

As a unique non-profit subsidiary of the Kühne Foundation, HELP Logistics AG has been advancing logistics excellence in the humanitarian and development sectors since 2014. Headquartered in Switzerland, we operate across the Middle East, Africa, Asia-Pacific and Europe. Our mission is to act as a global catalyst for advancing supply chain and logistics expertise to enhance the lives, opportunities, and resilience of people, communities, and economies worldwide. For more information, visit: https://www.help-logistics.org 

About Sanofi’s Global Health Unit 

Sanofi’s Global Health Unit is a pioneering, not-for-profit social business model with a mission to improve the lives of underserved populations in 40 countries with the highest unmet medical needs. We achieve this through innovative, inclusive healthcare models and partnerships, delivering a sustainable impact. Established in 2022, the Impact Investment Fund is focused on supporting the scale-up of businesses to improve access to healthcare by supporting startup companies and other innovators who can deliver scalable solutions for healthcare in underserved regions. For more information, visit: https://www.impact.sanofi/. 

About Chemonics International 

Founded in 1975, Chemonics is a leading global sustainable development firm for one reason: our people. We are 6,000+  professionals in more than 100 countries around the globe, and 90 percent of us are working in a community we’ve long called home. Our teams reflect a diversity of technical expertise and local knowledge because solving complex development challenges requires both. And as a company, we are committed to connections – global and local, human and technological – that allow learnings to efficiently flow and adapt between experts, projects, and countries. Where Chemonics works, development works.  Learn more at https://chemonics.com/. 

About Salient Advisory 

Launched in 2020 with a globally distributed team in Kenya, Nigeria and Canada, Salient Advisory helps changemakers enact transformative approaches to health. The company analyses and supports partnerships to use technology and innovations, adapt policy and financing, and elevate unheard voices to change global conversations and transform access to care. Learn more at https://www.salientadvisory.com/. 

About SCIDaR 

SCIDaR is an indigenous, Nigeria-based health systems consulting and implementation non-profit organisation that works with governments, development organisations, and the private sector to optimise population health outcomes. It applies proven business and market-shaping techniques and utilises its relationships and understanding of Africa's public and private sector health system actors to ensure sustainable impact. Learn more at https://scidar.org/.

About Chefaa

Chefaa is an AI-powered GPS enabled platform which enables patients to order, schedule and refill their prescriptions across Egypt. Orders can be fulfilled in 90 minutes through partner pharmacies or pre-scheduled at discounted prices. Differentiates itself through medication guides, medication reminders and telepharmacy services. Chefaa also provides data and insights for pharma companies, insurance and BNPL offerings to retail pharmacies. Learn more at www.chefaa.health.

About Dawa Mkononi

Dawa Mkononi is a B2B pharmaceutical supply chain platform leveraging technology and embedded financing to streamline medicine distribution for drug shops, pharmacies, clinics, and hospitals. Differentiates itself through AI-driven demand forecasting, real-time inventory tracking, and a buy-now-pay-later model powered by an in-house credit scoring system, ensuring fast, affordable, and compliant medicine procurement. Learn more at www.dawamkononi.co.tz.

About mPharma

mPharma enables access to health products through a vast chain of retail pharmacies operating across 8 countries. For providers, mPharma provides inventory management services, ensuring availability of quality medicines. For patients, mPharma provides a range of primary care services, leveraging nurses, physicians, and pharmacists. Learn more at www.mpharma.com.

About myDawa

MYDAWA is a hybrid digital and physical healthcare platform operating a bricks-and-clicks model to provide medications, teleconsultations, diagnostics, and insurance-integrated healthcare. Differentiates itself through vertically integrated generics manufacturing, which drives lower costs (up to 30%) and ensures quality, making healthcare more affordable and accessible. Learn more at www.mydawa.com.

About Meditect

Meditect is a B2B SaaS platform digitizing pharmacy management and data-driven healthcare analytics across Francophone Africa. Differentiates itself through cloud-based pharmacy management software, AI-powered credit scoring for instant financing, and data monetization for pharmaceutical companies and public health organizations. Learn more at www.meditect.com.

About Sproxil

Sproxil started as a mobile-based drug authentication platform tackling counterfeit medicines but has evolved into a comprehensive healthtech solution. In addition to its product protection and visibility offerings, it now provides real-time pharmaceutical market data (Sproxil Surveys), an AI-powered patient engagement platform (AISHA), and tech-driven accountability systems to improve supply chain transparency, medication safety, and public health decision-making. Learn more at www.sproxil.com.